These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 14503544)

  • 1. Preventing fungal infections in chronic granulomatous disease.
    Verweij PE; Warris A; Weemaes CM
    N Engl J Med; 2003 Sep; 349(12):1190-1; author reply 1190-1. PubMed ID: 14503544
    [No Abstract]   [Full Text] [Related]  

  • 2. Preventing fungal infections in chronic granulomatous disease.
    Franzblau MJ
    N Engl J Med; 2003 Sep; 349(12):1190-1; author reply 1190-1. PubMed ID: 14503545
    [No Abstract]   [Full Text] [Related]  

  • 3. Preventing fungal infections in chronic granulomatous disease.
    Berger VW
    N Engl J Med; 2003 Sep; 349(12):1190-1; author reply 1190-1. PubMed ID: 13679539
    [No Abstract]   [Full Text] [Related]  

  • 4. Itraconazole to prevent fungal infections in chronic granulomatous disease.
    Gallin JI; Alling DW; Malech HL; Wesley R; Koziol D; Marciano B; Eisenstein EM; Turner ML; DeCarlo ES; Starling JM; Holland SM
    N Engl J Med; 2003 Jun; 348(24):2416-22. PubMed ID: 12802027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trials and rare diseases.
    Lagakos SW
    N Engl J Med; 2003 Jun; 348(24):2455-6. PubMed ID: 12802033
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful treatment of aspergillus brain abscess with itraconazole and interferon-gamma in a patient with chronic granulomatous disease.
    Saulsbury FT
    Clin Infect Dis; 2001 May; 32(10):E137-9. PubMed ID: 11317265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A controlled clinical trial of itraconazole for prevention of fungal infections secondary to chemotherapy.
    Wang CY; Wu BY; Guo KY
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Apr; 23(4):389-90. PubMed ID: 12697487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and outcome of invasive fungal diseases in patients with chronic granulomatous disease: a multicenter study in France.
    Beauté J; Obenga G; Le Mignot L; Mahlaoui N; Bougnoux ME; Mouy R; Gougerot-Pocidalo MA; Barlogis V; Suarez F; Lanternier F; Hermine O; Lecuit M; Blanche S; Fischer A; Lortholary O;
    Pediatr Infect Dis J; 2011 Jan; 30(1):57-62. PubMed ID: 20700078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In meta-analysis itraconazole is superior to fluconazole for prophylaxis of systemic fungal infection in the treatment of haematological malignancy.
    Prentice AG; Glasmacher A; Djulbegovic B
    Br J Haematol; 2006 Mar; 132(5):656-8; author reply 658-9. PubMed ID: 16445845
    [No Abstract]   [Full Text] [Related]  

  • 10. Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients.
    Glasmacher A; Prentice A; Gorschlüter M; Engelhart S; Hahn C; Djulbegovic B; Schmidt-Wolf IG
    J Clin Oncol; 2003 Dec; 21(24):4615-26. PubMed ID: 14673051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of itraconazole prophylaxis for fungal infections after orthotopic liver transplantation: a prospective, randomized, double-blind study.
    Sharpe MD; Ghent C; Grant D; Horbay GL; McDougal J; David Colby W
    Transplantation; 2003 Sep; 76(6):977-83. PubMed ID: 14508365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive fungal infection in chronic granulomatous disease: insights into pathogenesis and management.
    Falcone EL; Holland SM
    Curr Opin Infect Dis; 2012 Dec; 25(6):658-69. PubMed ID: 22964947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Invasive fungal infection: challenge and choice].
    Weng XH; Huang XJ
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1441-2. PubMed ID: 16061015
    [No Abstract]   [Full Text] [Related]  

  • 14. An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.
    Glasmacher A; Cornely O; Ullmann AJ; Wedding U; Bodenstein H; Wandt H; Boewer C; Pasold R; Wolf HH; Hänel M; Dölken G; Junghanss C; Andreesen R; Bertz H;
    J Antimicrob Chemother; 2006 Feb; 57(2):317-25. PubMed ID: 16339606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic granulomatous lung infection caused by the dimorphic fungus Emmonsia sp.
    Wellinghausen N; Kern WV; Haase G; Rozdzinski E; Kern P; Marre R; Essig A; Hetzel J; Hetzel M
    Int J Med Microbiol; 2003 Dec; 293(6):441-5. PubMed ID: 14760976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Penetration and intracellular bioactivity of antibiotics. Role in the treatment of infections in children with chronic granulomatous disease].
    D'Elia R
    G Ital Chemioter; 1985; 32(2):505-10. PubMed ID: 3833595
    [No Abstract]   [Full Text] [Related]  

  • 17. Carriers of X-linked chronic granulomatous disease at risk.
    Roesler J
    Clin Immunol; 2009 Feb; 130(2):233; author reply 234. PubMed ID: 19004669
    [No Abstract]   [Full Text] [Related]  

  • 18. Strategies for managing systemic fungal infection and the place of itraconazole.
    Potter M
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i49-i54. PubMed ID: 16120634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic treatment with isotretinoin suppresses itraconazole blood level in chronic granulomatous disease.
    von Bernuth H; Wahn V
    Pediatr Allergy Immunol; 2014 Jun; 25(4):405-7. PubMed ID: 24383787
    [No Abstract]   [Full Text] [Related]  

  • 20. Micafungin (Mycamine) for fungal infections.
    Med Lett Drugs Ther; 2005 Jun; 47(1211):51-2. PubMed ID: 15961968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.